ArticleJournal of clinical microbiology2010

Human immunodeficiency virus type 1 protease inhibitor drug-resistant mutants give discordant results when compared in single-cycle and multiple-cycle fitness assays.

Carrie Dykes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.